Effect of MPC-11 myeloma and MPC-11 + IL-1 receptor antagonist treatment on mouse bone properties

Bone

Volumn 30, Issue 1, 2002, Pages 109-116

  Ferguson, V L ^a   Simske, S J ^a,d   Ayers, R A ^a   Bateman, T A ^a,e   Wang, H T ^a   Bendele, A ^b,d   Rich, B ^b   Collins, D ^b   Scherrer, J ^b   Sennello, R ^b,c   Colagiovanni, D B ^b,c  

^a University of Colorado at Boulder   (United States)

^b AMGEN INC   (United States)

^c GILEAD SCIENCES   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Department of Mechanical Engineering   (United States)

Author keywords

Bone resorption; Cortical bone; Interleukin 1 (IL 1); Interleukin 1 receptor antagonist (IL 1ra); MPC 11; Multiple myeloma

Indexed keywords

ALKALINE PHOSPHATASE; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MASS; CONTROLLED STUDY; CORTICAL BONE; FEMALE; LONG BONE; MORPHOMETRICS; MOUSE; MULTIPLE MYELOMA; MYELOMA; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; FEMALE; HYALURONIC ACID; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MULTIPLE MYELOMA; SIALOGLYCOPROTEINS;

EID: 0036138718     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00618-4     Document Type: Article

References (37)

1. Development of an in vivo model of human multiple myeloma bone disease
2. Mechanisms of bone destruction in multiple myeloma; The importance of an unbalanced process in determining the severity of lytic bone disease
3. Effects of interleukin-1 receptor antagonist in a slow-release hylan vehicle on rat type II collagen arthritis
4. Effects of interleukin-1 on bone turnover in normal mice
5. Effects of rehydration state on the flexural properties of whole mouse long bones
6. Role of bone marrow stromal cells in the growth of human multiple myeloma
7. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
8. Production of interleukin-1 by bone marrow stromal cells
9. The effects of drying and re-wetting on some mechanical properties of cortical bone
10. Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma; Effects of glucocorticoid therapy and disease activity
11. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma
12. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
13. Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo
14. The effects of a reduced calorie diet on bone mechanical properties in female C57BL/6J mice
15. Tetracycline-based histological analysis of bone remodeling
16. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells
17. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor
18. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1
19. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma
20. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma
21. Bone lesions produced by transplanted plasma-cell tumors in BALB/c mice
22. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone; Regulation by interleukin-1
23. Evidence for the secretion of an osteoclast stimulating factor in myeloma
24. Bone histomorphometry; Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
25. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro
26. Contribution of dietary and loading changes to the effects of suspension on mouse femora
27. Effects of suspension-induced osteopenia on the mechanical behavior of mouse long bones
28. An experimental model for combined neural, muscular, and skeletal degeneration
29. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption
30. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption
31. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors
32. New insights into role of microenvironment in multiple myeloma
33. Macrophage-hybridomas; Generation, structure and function
34. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage
35. Quantitative histology of myeloma-induced bone changes
36. Cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1
37. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells